These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. White NJ; Looareesuwan S; Warrell DA J Cardiovasc Pharmacol; 1983; 5(2):173-5. PubMed ID: 6188885 [TBL] [Abstract][Full Text] [Related]
5. A hitherto unreported pulmonary complication in an IV heroin user. Bishay A; Amchentsev A; Saleh A; Patel N; Travis W; Raoof S Chest; 2008 Feb; 133(2):549-51. PubMed ID: 18252922 [TBL] [Abstract][Full Text] [Related]
6. Lupus anticoagulant in the elderly may be associated with both quinine and quinidine usage. Bird MR; O'Neill AI; Buchanan RR; Ibrahim KM; Des Parkin J Pathology; 1995 Apr; 27(2):136-9. PubMed ID: 7567140 [TBL] [Abstract][Full Text] [Related]
7. Quinidine-induced arrhythmias. Pittman DE Med Times; 1980 Mar; 108(3):109, 113-5. PubMed ID: 7366356 [No Abstract] [Full Text] [Related]
8. Cotton fever: an evanescent process mimicking sepsis in an intravenous drug abuser. Torka P; Gill S J Emerg Med; 2013 Jun; 44(6):e385-7. PubMed ID: 23528959 [TBL] [Abstract][Full Text] [Related]
9. Adulterants in heroin/cocaine: implications concerning heroin-associated nephropathy. Cunningham EE; Venuto RC; Zielezny MA Drug Alcohol Depend; 1984 Sep; 14(1):19-22. PubMed ID: 6435983 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Krishna S; White NJ Clin Pharmacokinet; 1996 Apr; 30(4):263-99. PubMed ID: 8983859 [TBL] [Abstract][Full Text] [Related]
12. Drug fever caused by quinine and quinidine. Schlutz M; Zinneman HH; Hall WH Minn Med; 1973 Aug; 56(8):668-70. PubMed ID: 4733543 [No Abstract] [Full Text] [Related]
13. Accelerated transition to injection among male heroin initiates in Hanoi, Vietnam: implications for early harm reduction interventions. Clatts MC; Goldsamt LA; Giang le M; Colón-López V J Community Health; 2011 Dec; 36(6):999-1003. PubMed ID: 21452028 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH; van de Loo A; Baedeker F J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608 [TBL] [Abstract][Full Text] [Related]
15. [Chief health risks associated with intravenous heroin and cocaine abuse]. Ben Diane MK; Feroni I; Poncet M; Obadia Y Presse Med; 2000 Mar; 29(8):453-7. PubMed ID: 10738515 [TBL] [Abstract][Full Text] [Related]
16. [ECG examinations in 115 heroin addicts]. Benos J; Kutsampelas K Med Welt; 1980 Sep; 31(39):1400-2. PubMed ID: 7453525 [No Abstract] [Full Text] [Related]
17. Unusual injection neuropathy in heroin addict: case report. Finelli PF; Taylor GW Mil Med; 1977 Sep; 142(9):704-5. PubMed ID: 197453 [No Abstract] [Full Text] [Related]
18. [Dyspnea on exertion and bihilar space occupying lesion in intravenous cocaine/heroin abuse]. Sawatzki M; Keller DI Praxis (Bern 1994); 2007 Jun; 96(23):941-4. PubMed ID: 17585561 [TBL] [Abstract][Full Text] [Related]
19. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin. Valdez A; Cepeda A; Neaigus A; Russell A Int J Drug Policy; 2008 Dec; 19(6):442-9. PubMed ID: 19038723 [TBL] [Abstract][Full Text] [Related]
20. Understanding subtypes of inner-city drug users with a latent class approach. Kuramoto SJ; Bohnert AS; Latkin CA Drug Alcohol Depend; 2011 Nov; 118(2-3):237-43. PubMed ID: 21530105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]